ÂÜÀòÂÒÂ×

The Leadership Team at SciNeuro Pharmaceuticals comprises key executives including the Chief Scientific Officer (CSO), Founder & CEO, SVP Head of China Clinical Development, Chief Medical Officer, VP of Clinical Pharmacology/DMPK, and Vice President Head of Biologic Therapeutics. This team is responsible for setting strategic direction, guiding research and development, overseeing clinical trials, and ensuring that SciNeuro's novel therapeutic candidates advance efficiently through the pipeline towards regulatory approval and eventual market release. They ensure alignment across scientific, clinical, and business objectives to fulfill the company's mission of delivering transformative therapies for neurodegenerative and CNS diseases.